Mr. Power was diagnosed in 2018 with lymphoma. Building on his experience and his years of consulting about ways to change work processes using technology, he decided to help people with advanced cancer make complex decisions outside standard treatment options. He has run several “hackathons” (crowds convened to find the best next treatment) for patients and serves as an advisor to several startups reinventing cancer care.
In 2022 he launched Cancer Patient Lab with two advanced prostate cancer patients to help them and other patients make complex testing and treatment decisions, to learn, and to accelerate innovation. Brad hopes to make hackathons and other resources available to many more patients who are facing complex testing and treatment decisions.
Mr. Power is a founding member of ennov1; an advisor to 4DPath, Alva10, Consuli, Rabble Health, and Travera; and is an active contributor to the Personalized Medicine Coalition.